MENDS-on-FHIR: Leveraging the OMOP common data model and FHIR standards for national chronic disease surveillance

Competing Interest Statement

BZ and JA are affiliated with an organization that has funding from the Massachusetts Department of Public Health for support and development of Electronic Medical Record Support for Public Health (ESP) and MDPHnet, which is the underlying technology of MENDS. All other authors declare no competing interests.No copyrighted materials were used in this article.

Funding Statement

The "Improving Chronic Disease Surveillance and Management Through the Use of Electronic Health Records/Health Information Systems" project is supported by the Centers for Disease Control and Prevention (CDC) of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $2,500,000 with 100 percent funded by CDC/HHS. Disclaimer: The contents are those of the authors and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government. Additional funding from "A phenomics-first resource for interpretation of variants" project, supported by the National Human Genome Research Institute (5RM1HG010860-03: PI: Melissa Haendel). Institutional funding was provided by Health Data Compass and the Chief Research Informatics Office from the University of Colorado Anschutz Medical Campus. Andrey Soares was partially funded by the Harvard/STSI/NIH All of Us Program (Project #U24OD023716), project title: Technology to Empower Changes in Health (TECH) Network Participant Technologies Center -- Sync for Science (S4S).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Centers for Disease Control and Prevention (USA CDC) provided a written determination that MENDS operates within the public health authority pursuant to the Health Insurance Portability and Accountability Act. As a public health surveillance project, MENDS does not require institutional review board approval.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes